Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000124685 | SCV000168119 | benign | not specified | 2012-05-01 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
ARUP Laboratories, |
RCV001001507 | SCV001158810 | benign | Pyruvate dehydrogenase E2 deficiency | 2023-11-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001001507 | SCV001717469 | benign | Pyruvate dehydrogenase E2 deficiency | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001001507 | SCV001876765 | benign | Pyruvate dehydrogenase E2 deficiency | 2021-07-30 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000676206 | SCV005231582 | benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000676206 | SCV000801959 | benign | not provided | 2016-02-22 | no assertion criteria provided | clinical testing |